Introduction to Selank as a Research Peptide
Selank is a synthetic heptapeptide composed of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Originally developed in the Laboratory of Protein Hormones and Immunomodulators at the Institute of Molecular Genetics of the Russian Academy of Sciences, this compound has attracted considerable attention from research institutions worldwide for its investigation in neurological and immunological experimental models. Its primary structure is derived from the natural immunopeptide tuftsin (Thr-Lys-Pro-Arg), with the addition of a Pro-Gly-Pro tripeptide at the C‑terminus, which extends its stability in biological media compared to the native fragment. Preclinical studies have examined Selank’s interaction with neurotransmitter systems, including changes in monoamine levels and gamma‑aminobutyric acid (GABA) receptor binding, as well as its influence on cytokine expression profiles in cell cultures and laboratory animals.
For laboratories focused on reproducible and rigorous data, obtaining the peptide from a Selank 99 percent purity supplier is a prerequisite. Contaminants such as incomplete sequences, deletion peptides, or residual solvents can alter experimental outcomes, particularly in sensitive techniques like radioligand binding assays, patch-clamp electrophysiology, or gene expression profiling. High‑purity Selank (≥99%) minimizes these confounding variables, thereby supporting the internal validity of research projects. Whether the objective is to investigate nootropic-like effects in rodent behavioral models or to probe immunomodulatory pathways in vitro, starting material of documented purity establishes a reliable baseline for data interpretation.
Why Purity Matters in Research-Grade Peptides
The presence of even trace impurities in a peptide sample can significantly skew experimental results. In cell‑based assays, truncated or misfolded sequences may trigger unintended receptor activation or apoptosis, masking true biological responses. During binding and kinetic studies, non‑cognate peptides compete for the target site, leading to inaccurate Kd o IC50 calculations. In animal models, side products from synthesis can provoke immune reactions or metabolic interference that confound pharmacokinetic and pharmacodynamic measurements. Consequently, adopting a purity threshold of 99% — defined as the weight percentage of the target peptide relative to total peptidic content — has become a consensus standard among academic laboratories and pharmaceutical discovery units.
Verifying that a batch meets this specification demands a multi‑technique analytical approach. Reversed‑phase high‑performance liquid chromatography (RP‑HPLC) with ultraviolet detection at 214–220 nm quantifies peptidic impurities, while mass spectrometry (typically electrospray ionization, ESI, or matrix‑assisted laser desorption/ionization, MALDI‑TOF) confirms the monoisotopic mass matches the theoretical value for the oxidized or reduced form. Amino acid analysis further validates the peptide composition. A true Selank 99 percent purity supplier will supply all these data for every lot, enabling the researcher to assess lot‑to‑lot consistency before embarking on critical experiments. Without this transparency, the risk of irreproducible results increases, wasting both time and grant resources.
Selecting a Reliable Selank Supplier
Identifying a trustworthy peptide partner involves more than comparing catalog prices. A credible supplier provides a Certificate of Analysis (COA) for each batch that includes, at a minimum, the net peptide content (as determined by amino acid analysis or nitrogen content), HPLC purity expressed as an area percentage, mass spectrometric data, appearance, solubility observations, and explicit storage recommendations. The COA should be traceable to a specific lot number and dated within a recent timeframe. Suppliers that practice current Good Manufacturing Practice (cGMP) principles — even for research‑use‑only materials — typically demonstrate superior process control and lower inter‑batch variability.
Transparency is another key indicator. The supplier should be willing to discuss the synthesis route, the quality of starting raw materials, and the details of their purification and lyophilization steps. A reliable source will also maintain retained samples from each production campaign, enabling comparative analysis should a customer report an issue. When evaluating a Selank 99 percent purity supplier, request example COAs and check whether the documentation is consistent and complete. A supplier that hesitates to share analytical data or hides behind generic statements may not be equipped to support rigorous laboratory research.
Quality Control and Analytical Data
A robust quality‑control programme for Selank typically encompasses the following tests, all performed on the final lyophilized powder:
- HPLC Purity: ≥99.0% as measured by RP‑HPLC area normalization at 214 nm. The method uses a C18 column and a gradient of acetonitrile in water with 0.1% trifluoroacetic acid (TFA). Any impurity eluting at a relative retention time different from the main peak is integrated and reported.
- Mass Spectrometry: ESI‑MS or MALDI‑TOF analysis to determine the molecular ion [M+H]+. For Selank, the monoisotopic mass is 751.4 Da; experimental values within ±1.0 Da are considered acceptable.
- Water Content: Determined by coulometric Karl Fischer titration. Typical specifications require ≤10% (w/w), as excess moisture can accelerate peptide degradation.
- Residual TFA: Ion chromatography or 19F‑NMR quantifies TFA remaining from the cleavage step. A limit of ≤1% is standard for research‑grade material.
- Endotoxin Levels: For experiments involving cell cultures or sensitive in vivo protocols, endotoxin must be measured by the Limulus amebocyte lysate (LAL) assay. Low‑endotoxin batches (≤0.5 EU/mg) are available upon request and are essential for immunology-focused research.
- Batch‑to‑Batch Reproducibility: Each new lot is compared to a reference standard using HPLC and MS. Retained samples are stored under accelerated and long‑term conditions to monitor stability and provide confidence to repeat purchasers.
All these data points are consolidated into the COA, giving the end user a comprehensive fingerprint of the peptide’s identity and quality.
Manufacturing and Sourcing Standards
Selank is manufactured via solid‑phase peptide synthesis (SPPS) employing the Fmoc (9‑fluorenylmethoxycarbonyl) protection strategy on a Wang or Rink amide resin. Stepwise coupling is performed with activators such as HBTU/HOBt in the presence of a tertiary amine base. Each coupling and deprotection is monitored by Kaiser or TNBS testing to ensure high efficiency; after assembly, the peptide is cleaved from the resin with a TFA‑based cocktail containing scavengers (water, triisopropylsilane) to liberate the crude peptide and remove side‑chain protecting groups.
Raw materials — Fmoc‑amino acids, resins, coupling reagents, and solvents — are procured from certified chemical manufacturers who provide their own certificates of analysis and, where applicable, statements of animal‑free origin. The production facility maintains environmental controls: temperature 18–24 °C, relative humidity below 40%, and ISO‑classified cleanrooms for the critical stages of purification and lyophilization. Crude peptide is purified by preparative RP‑HPLC to ≥99% purity, concentrated, and lyophilized. The final powder is then dispensed into pre‑sterilized vials and sealed under argon or nitrogen to displace oxygen. Every step is documented, creating a batch record that underpins the supplier’s claim of being a Selank 99 percent purity supplier.
Handling and Storage Recommendations for Selank
Upon receipt, Selank should be visually inspected and immediately stored under the conditions specified in the COA. As a lyophilized powder, it is hygroscopic and sensitive to light; therefore, vials must be kept desiccated and protected from direct illumination. The recommended storage temperature is –20 °C, although –80 °C is preferable for archival storage beyond a few months. Under these conditions, stability studies indicate a shelf life of at least two years from the date of synthesis, with no significant change in HPLC purity or peptide content.
For reconstitution, researchers typically use sterile water for injection (WFI), phosphate‑buffered saline (PBS, pH 7.4), or another buffer compatible with the intended experiment. It is critical to first bring the vial to room temperature to avoid condensation, then add the solvent gently along the inner wall, allowing the powder to dissolve by swirling rather than vortexing, which can cause aggregation. The reconstituted solution should be aliquoted immediately into single‑use portions and stored at –20 °C; repeated freeze‑thaw cycles can promote peptide degradation and loss of biological activity. Once thawed, an aliquot should be used promptly and any leftover solution discarded. Data from accelerated stability testing suggest that Selank in solution is stable for up to one month at –20 °C, provided it is protected from light and microbial contamination.
Ordering Selank for Your Laboratory
Most Selank 99 percent purity supplier catalogs offer the peptide in standard sizes ranging from 5 mg to 100 mg, suitable for initial dose‑response studies in cell culture or small‑scale animal experiments. For larger projects, such as repeated behavioral testing in rodents or extensive in vitro screening, custom synthesis can be arranged with quantities up to gram scale. When placing an order, verify whether the quoted purity refers to HPLC area percent or net peptide content, as these metrics can differ.
Packaging is optimized for thermal stability and integrity during transit: each vial is double‑sealed with a rubber stopper and an aluminum crimp cap, often under an inert argon or nitrogen overlay. The vials are then placed in a secondary container with desiccant. International shipments are dispatched with cold packs or dry ice, depending on the destination and transit time, and temperature loggers can be included upon request. Some countries classify synthetic peptides as biochemicals that require an import permit or a letter of no‑objection from a regulatory authority; therefore, buyers should ascertain their local regulations before finalizing an order. The supplier’s logistics team can typically provide the necessary harmonized system (HS) codes and a pro‑forma invoice to facilitate customs clearance.
Frequently Asked Questions (FAQ)
- What purity level do you guarantee for Selank? Each batch is tested by RP‑HPLC and reported with a detailed COA. We guarantee ≥99% purity by area normalization. The corresponding mass spectrum and, if requested, amino acid analysis data are available for every lot.
- Can Selank be used in cell culture experiments? Yes, when endotoxin levels are within acceptable limits for your specific cell line. We offer low‑endotoxin versions (≤0.5 EU/mg) tested by the LAL assay. If your protocol requires an even stricter threshold, please contact our scientific support team to discuss custom QC testing.
- What documentation is provided with each order? A complete documentation package includes the COA with HPLC and MS data, a solubility guide, and a safety data sheet (SDS). An amino acid analysis report can be added at no extra charge. All documents are linked to the unique lot number and are archived electronically for easy retrieval.
- Is Selank suitable for in vivo research? Selank may be used in laboratory animal studies conducted under appropriate ethical protocols and institutional animal care and use committee approvals. It is not intended for administration to humans or for any clinical application. All orders are processed under the understanding that the material will be employed strictly for non‑clinical research.
Solo para uso en investigación: All products described herein are intended solely for in vitro laboratory research or for use in laboratory animals under approved protocols. They are not manufactured, tested, or authorized for diagnostic, therapeutic, or any other human or veterinary purpose. Statements regarding product characteristics have not been evaluated by the U.S. Food and Drug Administration, the European Medicines Agency, or any other regulatory body.
Solo para uso en investigación. No apto para uso humano ni veterinario.
